Screener
CRISPR Therapeutics CRSP Book value per share
Book value per share at other companies
Other financials
Where this comes from
Calculated from CRISPR Therapeutics’s reported figures.
Based on the most recent quarter.
The source filing: CRISPR Therapeutics’s 10-Q, filed May 4, 2026. Open the filing →
- Filed
- May 4, 2026, 4:48 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-204188
FAQ
- What is CRISPR Therapeutics's book value per share?
- CRISPR Therapeutics (CRSP) reported book value per share of $18.89 in Q1 2026.
- How has CRISPR Therapeutics's book value per share changed year-over-year?
- CRISPR Therapeutics's book value per share decreased by 11.2% year-over-year, from $21.28 to $18.89.
- What is the long-term trend for CRISPR Therapeutics's book value per share?
- Over 5 years (2020 to 2025), CRISPR Therapeutics's book value per share has grown at a -1.8% compound annual growth rate (CAGR), from $23.35 to $21.37.
- What does book value per share mean?
- Shareholders' equity divided by diluted shares outstanding at the quarter end. The accounting (book) value attributable to each share.
Ask your AI about CRISPR Therapeutics's book value per share.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude